Resources

4 Resources for

everyday finance and healthcare

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Gene Patenting Will Hinder Biotechs and Drugmakers from Curing Maladies
Dan Pritch submits: I read with interest this article outlining how a company and university have patented two human genes linked to breast and ovarian cancers. Now, the ACLU is suing Myriad Genetics MYGN on the grounds that it is unconstitutional [to patent genes] and will inhibit innovation. I...
Tags: Biotech, Healthcare, Everyday Finance, Myriad Genetics Inc.
External links 2009-05-14
Swine Flu Stocks Fizzle Out After Impressive Open
Dan Pritch submits: When I initially posted about swine flu stocks and investments likely to benefit from the worsening news out of Mexico and the US this past weekend, I anticipated some additional follow through from Friday, but nothing like what we saw at the open Monday. Some of...
Tags: Healthcare, US Market, Everyday Finance, Novavax
External links 2009-04-27
Little Known Healthcare Services Has Increased Dividends for 24 Consecutive Quarters
Dan Pritch submits: Through a rather obscure screening, I came across a relatively small company that has increased its dividends for 24 consecutive quarters, including another announcement this week. Now that spreads are shrinking on the high yield muni bond mania and with high yield corporate bond ETFs...
Tags: Healthcare, Everyday Finance, Healthcare Services Group Inc.
External links 2009-04-17
Lilly Litigation Begs the Question - Should Whistleblower Employees Profit?
Dan Pritch submits: In news that was anticipated since Lilly LLY disclosed in October that it was setting aside litigation funds, the drug giant reached a settlement with the US Attorney's office in Philadelphia for $1.4 Billion for allegedly marketing the antipsychotic Zyprexa to patients who didn't need it....
Tags: Healthcare, Everyday Finance, Eli Lilly & Co.
External links 2009-01-15
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement
Click Here